In Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. (June 4, 2026), a unanimous Supreme Court has further clarified what it takes to plead — and ultimately prove — that a defendant induced another party to infringe a patent, setting a high bar for induced infringement claims. While the case arose in the context of
Latest Post
More Posts
Is “Material Contribution” to Another’s Infringement Enough to Establish Liability for Contributory Copyright Infringement?
The Supreme Court’s Decision on Indirect Internet Copyright Liability Could Have Far-Reaching Effects
Noncompetes Are in the NLRB’s Crosshairs – Can Trade Secret Protections Save Them?
Collision at the Intersection of Construction and Intellectual Property Law: Are You Protecting Your Firm’s Trade Secrets?
Are You Protecting Your Construction Firm’s Trade Secrets?
Subscribe: Subscribe via RSS
Blogs
Firm/Org